Research at the Comprehensive Cancer Center Freiburg – CCCF
From foundations to clinical applicationsThe dual focus of our efforts is to offer our patients interdisciplinary, innovative, and comprehensive care and to promote translational cancer research.
In the context of clinical trials, we can provide patients with the earliest possible access to promising new diagnostic and therapeutic concepts. The patients in question thus benefit from novel scientific approaches. The translation of research findings into clinical trials is facilitated by the Clinical Trials Unit and by early clinical trial units (ECTU) for adults and for children.
Gastrointestinal
Frauenheilkunde
| Dr. B. Rautenberg | Breast Cancer (in German) |
| Dr. B. Rautenberg | Ovarian Cancer (in German) |
| Prof. Dr. M. Klar | Uterine cancer (in German) |
Hematology/Oncology
| AG Becker | |
AG DuqueAcute leukemias and allogeneic stem cell transplantation | Acute leukemias and allogeneic stem cell transplantation |
| AG Duyster | |
| AG Frew | |
AG Hartmann | Microenvironment-induced therapy resistance in leukemia and lymphoma |
AG Illert | Moleculare oncology – Signal transduction of oncogenic tyrosine kinases |
AG Köhler | Tumor immunology and T cell based immunotherapies |
| Lübbert Laboratory | Cancer Epigenetics |
| AG Pahl | Section for Molecular Hematology |
| AG Scherer | Developing improved molecular biomarkers and novel prognostic and predictive models |
| AG Zeiser | Alloimmune regulation |
Skin Tumors
| Freiburg Skin tumor Center | Malignant skin tumors: Intralesional therapies and tumor stem cells / Psycho-oncological care of skin cancer patients |
Molecular Medicine
| AG Reinheckel | In vivo functions of proteases |
| AG Brummer | Signal transduction in tumor development and drug resistance |
| Max Eder Nachwuchsgruppe | https://www.uniklinik-freiburg.de/chirurgie/forschung/max-eder-gruppe-ruess.html |
Neurosurgery
| Prof. Dr. O. Schnell | Translational NeuroOncology Research Group |
| PD Dr. D.H. Heiland | Microenvironment and Immunology Research Laboratory |
| Fr. PD Dr. M.S. Carro | Genetics of Brain Tumors Research Group |
| Fr. Prof. Dr. M. Machein | Neurooncological Health Care Research Group |
| Prof. Dr. J.-H. Klingler, Fr. Dr. C. Steiert | Hemangioblastoma and von Hippel-Lindau (VHL) Disease Research Group |
| Prof. Dr. T. Ball | Neuromedical AI Lab |
| Prof. Dr. O. Schnell, Fr. Dr. D. Cipriani | Clinical Trial Unit |
Esophageal Carcinoma
| Department of General and Visceral Surgery | Minimally invasive surgery for esophageal tumors |
| Gastrointestinal Oncology Working Group | https://www.uniklinik-freiburg.de/medizin2/forschung/experimentelle-forschung/ag-quanteheeg.html (in German) |
| ESOPEC-Trial | https://www.uniklinik-freiburg.de/esopec-studie.html (in German) |
Oncoimmunology
| Oncoimmunology Research Group | Immunological and microbial processes in the tumor microenvironment of inflammation-associated and spontaneous colorectal carcinomas. |
Oncological Theranostics
Pediatrics
AG Erlacher | |
AG Flotho | EPIdiagnosis and EPItherapy of juvenile myelomonocytic leukemia |
AG Hettmer | |
AG Kapp | |
AG Ku | |
AG Strahm | Rare Blood Disorders and Hematopoietic Stem Cell Transplantation |
AG Zieger | Inherited and acquired disorders of primary and secondary hemostasis |
Pathology
| AG Bronsert | Malignant epithelial tumors of the gastrointestinal tract (focus on the pancreatobiliary system) and the female reproductive organs (focus on the mamma) |
| Core Facility für Histopathologie und Digitale Pathologie | Core Facility für Histopathologie und Digitale Pathologie |
| Biobank | Biobank des Comprehensive Cancer Centers |
| AG Schilling | Translational proteomics and proteolytic signaling |
| AG Schell | MatriPath - Lab (Laboratory for Experimental Nephropathology and Urological Malignancies) |
Nachwuchsgruppe “MALDI imaging” | Mass spectrometry imaging in order to find molecular characteristics. |
Plastic Surgery
| AG Eisenhardt/ Braig | |
| AG Eisenhardt Diagnostics | Diagnostic biomarkers for soft tissue sarcomas |
Radiopharmaceutical Development
| AG Eder | Identification of novel radiopharmaceuticals in the field of diagnostic and therapeutic medicine |
Radiation Oncology
| Research in radiation oncology | https://www.uniklinik-freiburg.de/strahlenklinik/forschung.html |
| Baltas Research Group | Division of Medical Physics |
| AG Schäfer | |
| AG Niedermann | Section of Radiobiology |
| AG Zamboglou | Section of Interventional Radiotherapy |
| AG Heinemnann | Clinical and Administrative Informatics Functional Area (in German) |
CNS Lymphomas
PD Dr. Tanja Hartmann
Telephone: +49 (0)761 270-71511
tanja.hartmann@uniklinik-freiburg.de